ReviewMolecular & cellular oncology
Trial Watch: Targeting ATM-CHK2 and ATR-CHK1 pathways for anticancer therapy.
Gwenola Manic et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
93 papers cite itlatest 60 shown
cites it
ReviewMolecular & cellular oncology
Gwenola Manic et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.